• Explore /
  • Poster
  • / Genomics to select treatment for patients (pts) with metastatic cancer: Final analysis of Molecular Tumor Board (MTB) evaluations in the ROME trial.

Genomics to select treatment for patients (pts) with metastatic cancer: Final analysis of Molecular Tumor Board (MTB) evaluations in the ROME trial.

Abstract Poster

Authors

null

Andrea Botticelli

Department of Radiology, Oncology and Pathology, “Sapienza” University of Rome, Rome, Italy

Andrea Botticelli , Simone Scagnoli , Pierfranco Conte , Chiara Cremolini , Paolo Antonio Ascierto , Federico Cappuzzo , Massimo Aglietta , Federica Mazzuca , Ettore Capoluongo , Giovanni Blandino , Umberto Malapelle , Marianna Nuti , Giulia D'Amati , Bruna Cerbelli , Giancarlo Pruneri , Mauro Biffoni , Giuseppe Giannini , Francesco Cognetti , Giuseppe Curigliano , Paolo Marchetti

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Other Developmental Therapeutics

Clinical Trial Registration Number

NCT04591431

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 3157)

DOI

10.1200/JCO.2024.42.16_suppl.3157

Abstract #

3157

Poster Bd #

302

Abstract Disclosures

Similar Posters

First Author: Birgit Geurts

First Author: Andrea Botticelli

First Author: Yuki Matsubara

First Author: Jean-Charles Soria